Header Logo

Connection

Leslie Shaw to Amifostine

This is a "connection" page, showing publications Leslie Shaw has written about Amifostine.
Connection Strength

1.007
  1. Bonner HS, Shaw LM. New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion. J Clin Pharmacol. 2002 Feb; 42(2):166-74.
    View in: PubMed
    Score: 0.195
  2. Shaw LM, Bonner HS, Schuchter L, Schiller J, Lieberman R. Pharmacokinetics of amifostine: effects of dose and method of administration. Semin Oncol. 1999 Apr; 26(2 Suppl 7):34-6.
    View in: PubMed
    Score: 0.160
  3. Shaw LM, Bonner H, Lieberman R. Pharmacokinetic profile of amifostine. Semin Oncol. 1996 Aug; 23(4 Suppl 8):18-22.
    View in: PubMed
    Score: 0.133
  4. Shaw LM, Bonner HS, Brown DQ. Metabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse. Drug Metab Dispos. 1994 Nov-Dec; 22(6):895-902.
    View in: PubMed
    Score: 0.118
  5. Brown DQ, Graham WJ, MacKenzie LJ, Pittock JW, Shaw LM. Can WR-2721 be improved upon? Pharmacol Ther. 1988; 39(1-3):157-68.
    View in: PubMed
    Score: 0.073
  6. Shaw LM, Glover D, Turrisi A, Brown DQ, Bonner HS, Norfleet AL, Weiler C, Glick JH, Kligerman MM. Pharmacokinetics of WR-2721. Pharmacol Ther. 1988; 39(1-3):195-201.
    View in: PubMed
    Score: 0.073
  7. Shaw LM, Turrisi AT, Glover DJ, Bonner HS, Norfleet AL, Weiler C, Kligerman MM. Human pharmacokinetics of WR-2721. Int J Radiat Oncol Biol Phys. 1986 Aug; 12(8):1501-4.
    View in: PubMed
    Score: 0.067
  8. Levi M, Knol JA, Ensminger WD, DeRemer SJ, Dou C, Lunte SM, Bonner HS, Shaw LM, Smith DE. Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys. Drug Metab Dispos. 2002 Dec; 30(12):1425-30.
    View in: PubMed
    Score: 0.052
  9. Bonner HS, Shaw LM. Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2000 Mar 10; 739(2):357-62.
    View in: PubMed
    Score: 0.043
  10. Ben-Josef E, Mesina J, Shaw LM, Bonner HS, Shamsa F, Porter AT. Topical application of WR-2721 achieves high concentrations in the rectal wall. Radiat Res. 1995 Jul; 143(1):107-10.
    View in: PubMed
    Score: 0.031
  11. Shpall EJ, Stemmer SM, Hami L, Franklin WA, Shaw L, Bonner HS, Bearman SI, Peters WP, Bast RC, McCulloch W, et al. Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support. Blood. 1994 Jun 01; 83(11):3132-7.
    View in: PubMed
    Score: 0.029
  12. Nakamura J, Shaw LM, Brown DQ. Hydrolysis of WR2721 by mouse liver cell fractions. Radiat Res. 1987 Jan; 109(1):143-52.
    View in: PubMed
    Score: 0.017
  13. Risley JM, Van Etten RL, Shaw LM, Bonner H. Hydrolysis of S-2-(3-aminopropylamino)ethylphosphorothioate (WR-2721). Biochem Pharmacol. 1986 May 01; 35(9):1453-8.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.